Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 September 2018 Photo Stephen Collett
Outstanding Alumni awarded
Attending the awards evening were from the left: Dr Mafu Rakometsi; Gustav Wilson; Dr Pieter du Toit, National Executive Alumni Chairperson; Ace Moloi; Dr Khotso Mokhele; Prof Dave Lubbe; Dr Suzanne Staples; Prof Francis Petersen; Bertus Jacobs, and Tshepo Moloi.
A medical doctor, an economist, an author, and experts in the fields of Information Technology, Education, Management and Sociology are the winners of this year’s Chancellor’s Distinguished Alumni Awards. 

This is the 36th year that the UFS honours those alumni who are not only flying the Kovsie flag high, but are inspiring excellence and transforming lives.

Chancellor’s Challenge

UFS Chancellor Dr Khotso Mokhele had a sobering message for those who attended the awards ceremony on 8 September. He shared how, on a recent visit to the US, he had a chance to visit the campus of Facebook in Seattle, and heard how every year Facebook received more than two million CVs from prospective employees – 98% of whom sported A-average grades. Management then confided in him that they never hired a CV, but rather a mindset.

“They sift through all those applications, looking for someone with a vision to disrupt the status quo,” Mokhele said. “This continent will be left behind if we don’t adopt that mindset – that confidence that borders on arrogance – that we can change the world. Are we ready for that challenge?” 

The recipients in the various categories are:

Chancellor's Distinguished Alumnus of the Year:       
Danie Meintjes – Former Group Chief Executive Officer of Mediclinic

Cum Laude Awards
Dr Mafu Rakometsi ¬ Chief Executive Officer of the Council for Quality Assurance in General and Further Education and Training (Umalusi)
Dr Suzanne Staples, Principal Investigator at the Tuberculosis & HIV Investigative Network (THINK)

Kovsie Ambassador Awards
Tshepo Moloi – Economist at the South African Reserve Bank
Bertus Jacobs – Chief Technology Officer at IoT.nxt
Gustav Wilson, Regional Head (Development and Care) Department of Correctional Services 

Executive Management Award
Prof Dave Lubbe – Research Fellow and Professor at UFS School of Accountancy.

Young Alumnus of the Year
Ace Moloi – Author and literary consultant

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept